Embryonal Childhood Rhabdomyosarcoma Clinical Trial
Official title:
Observational - CRKL Expression at the Protein Level in Rhabdomyosarcoma Tumors by Tissue Microarray (TMA)
This research trial studies biomarkers in tumor tissue samples from younger patients with rhabdomyosarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
PRIMARY OBJECTIVES:
I. To demonstrate CRKL expression at the protein level in rhabdomyosarcoma tumors by tissue
microarray (TMA).
OUTLINE:
Archived tumor tissue samples are analyzed for CRKL expression.
;
Observational Model: Case-Only, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00075582 -
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
|
Phase 3 | |
| Completed |
NCT00003958 -
Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
|
Phase 3 | |
| Completed |
NCT00025363 -
Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma
|
Phase 2 | |
| Completed |
NCT01626170 -
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma
|
N/A | |
| Completed |
NCT01609803 -
Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma
|
N/A | |
| Completed |
NCT00331643 -
Ixabepilone in Treating Young Patients With Refractory Solid Tumors
|
Phase 2 | |
| Completed |
NCT06040229 -
Retrospective Study in FFPE Samples From Younger Patients With Rhabdomyosarcoma
|